Publication details

Epidemiologie, hospitalizační léčba a migrace IBD pacientů za specializovanou péčí v České Republice

Title in English Epidemiology, hospitalization and migration of patients with IBD under specialized care in the Czech Republic
Authors

JARKOVSKÝ Jiří BENEŠOVÁ Klára HEJDUK Karel DUŠEK Ladislav LUKÁŠ M.

Year of publication 2017
Type Article in Periodical
Magazine / Source Gastroenterologie a hepatologie
MU Faculty or unit

Faculty of Medicine

Citation
Keywords Crohn's disease; Epidemiology; Hospitalization; Mortality; Ulcerative colitis
Description Aim: To analyse data obtained by the Institute of Health Information and Statistics of the Czech Republic (IHIS CR)from patients with Crohn's disease (CD) and ulcerative colitis (UC) under specialized care in terms of incidence, prevalence, hospitalization, mortality and patient migration. Patients and Methods: We analysed data from 19,797,081 hospitalization records, a database of death records, annual gastroenterology reports and the Czech National Cancer Registry related to the diagnosis of CD and UC in 2007-2015 obtained by the IHIS CR. Results: The incidence of CD and UC sharply increased over this period and reached 22.7 and 27.9 cases per 100,000 people, respectively. A total of 46,608 patients were followed up in the Czech Republic. The mortality rate of CD patients was relatively low and remained stable overtime at around 0.4%. By contrast, the mortality rate of UC patients was 6-fold higher and was particularly high in those who underwent surgery. Surprisingly, only 60 UC patients were operated on annually. As expected, the most important healthcare sites dedicated to the management of inflammatory bowel disease (IBD) are located in the largest cities of the Czech Republic, including teaching and non-teaching hospitals in Prague, Brno, Ostrava and Hradec Kralove. Conclusions: This study analysed data obtained by the IHIS CR. The prevalence of IBD was higher than expected and its incidence increased recent years. The mortality rate of UC patients was 6-fold higher than that of CD patients.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info